Moreover, JS‐K administration also significantly suppressed the expression of SOD1 and catalase in gastric tumour tissues (Figure 6I), indicating that JS‐K down‐regulates SOD1 and catalase in vivo. This evidence concerns the gene SOD1 and gastric neoplasm.